Skip to content

Effect of Garlic Tablet Some Indicators Related to Atherosclerosis

Effect of Garlic Tablet on Carotid Intima Media Thickness and Flow-mediated Dilation in Patients Undergoing Angioplasty

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01948453
Enrollment
56
Registered
2013-09-23
Start date
2013-08-31
Completion date
2014-09-30
Last updated
2015-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Keywords

CAD, CIMT, FMD

Brief summary

The purpose of this study is to determine whether garlic in adjunct to conventional medical treatment is effective in improving carotid intima media thickness (CIMT), Flow mediated dilation (FMD) and plasma lipid profile or c-reactive protein of coronary artery disease (CAD) patients.

Interventions

DIETARY_SUPPLEMENTGarlic

Garlic tablet in adjunct to medical treatment

Sponsors

Shahid Beheshti University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
25 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* angiography confirmed coronary artery disease * lack of consistent use of the garlic in the last month

Exclusion criteria

Change in type of medication during study

Design outcomes

Primary

MeasureTime frameDescription
Carotid Intima Media Thickness12 weeksChange from baseline and compared to placebo group in Carotid Intima Media Thickness at 12 weeks

Secondary

MeasureTime frameDescription
Flow-mediated dilatation12 weeksChange from baseline and compared to placebo group in Flow-mediated dilatation at 12 weeks

Other

MeasureTime frameDescription
plasma levels of Alanine Aminotransferase, Aspartate Aminotransferase, creatinine, lipid profile, C-Reactive Protein12 weeksChange from baseline in plasma levels at 12 weeks

Countries

Iran

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026